Iridex to Present at the 2021 Stifel Virtual Healthcare Conference

Rhea-AI Summary

Iridex Corporation (Nasdaq: IRIX) announced participation in the 2021 Stifel Virtual Healthcare Conference, scheduled for November 16, 2021, at 2:00 pm ET. David Bruce, President and CEO, will present, and interested parties can access the live and archived webcast at www.iridex.com. Iridex specializes in ophthalmic laser-based medical products targeting glaucoma and retinal diseases, utilizing proprietary MicroPulse technology for effective treatments. Their products are distributed in over 100 countries, enhancing patient care globally.

MOUNTAIN VIEW, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming 2021 Stifel Virtual Healthcare Conference.

David Bruce, Iridex’s President and Chief Executive Officer, is scheduled to present on Tuesday, November 16, 2021, at 2:00 pm ET. Interested parties may access a live and archived webcast of the presentation at www.iridex.com.

About Iridex
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse^® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When will Iridex present at the Stifel Virtual Healthcare Conference?

Iridex is scheduled to present on November 16, 2021, at 2:00 pm ET.

Where can I access Iridex's presentation webcast?

The live and archived webcast can be accessed at www.iridex.com.

What medical conditions do Iridex products treat?

Iridex products treat glaucoma, diabetic macular edema, and other retinal diseases.

What technology does Iridex use in its products?

Iridex utilizes proprietary MicroPulse technology in its laser-based medical systems.

In how many countries are Iridex products sold?

Iridex products are sold in over 100 countries worldwide.